0
0

Colorectal Cancer Detection Act

12/15/2023, 4:06 PM

Congressional Summary of S 892

Colorectal Cancer Detection Act

This bill provides for Medicare coverage and payment, subject to specified frequency limits, of certain colorectal cancer screening blood-based tests.

Current Status of Bill S 892

Bill S 892 is currently in the status of Bill Introduced since March 21, 2023. Bill S 892 was introduced during Congress 118 and was introduced to the Senate on March 21, 2023.  Bill S 892's most recent activity was Read twice and referred to the Committee on Finance. as of March 21, 2023

Bipartisan Support of Bill S 892

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
2
Democrat Cosponsors
1
Republican Cosponsors
1
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 892

Primary Policy Focus

Health

Potential Impact Areas

- Blood and blood diseases
- Cancer
- Digestive and metabolic diseases
- Health promotion and preventive care
- Medical tests and diagnostic methods
- Medicare

Alternate Title(s) of Bill S 892

Colorectal Cancer Detection Act
Colorectal Cancer Detection Act
A bill to amend title XVIII of the Social Security Act to provide coverage under the Medicare program for FDA-approved qualifying colorectal cancer screening blood-based tests, to increase participation in colorectal cancer screening in under-screened communities of color, to offset the COVID-19 pandemic driven declines in colorectal cancer screening, and for other purposes.

Comments